CM Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,000
| Closed | -$11K | – | 73 |
|
|
2023
Q2 | $11K | Hold |
6,000
| – | – | 0.01% | 73 |
|
|
2023
Q1 | $22K | Sell |
6,000
-11,500
| -66% | -$42.2K | 0.03% | 62 |
|
|
2022
Q4 | $67K | Sell |
17,500
-5,000
| -22% | -$19.1K | 0.08% | 70 |
|
|
2022
Q3 | $178K | Buy |
22,500
+4,000
| +22% | +$31.6K | 0.2% | 70 |
|
|
2022
Q2 | $389K | Buy |
18,500
+2,250
| +14% | +$47.3K | 0.41% | 62 |
|
|
2022
Q1 | $611K | Buy |
16,250
+8,750
| +117% | +$329K | 0.51% | 58 |
|
|
2021
Q4 | $422K | Buy |
7,500
+3,750
| +100% | +$211K | 0.32% | 77 |
|
|
2021
Q3 | $271K | Buy |
+3,750
| New | +$271K | 0.2% | 84 |
|